Muscular Dystrophy Association

• NCT05412394

  Collaborator, Phase 4, Recruiting, 26 people, 9 Jun 2022

• NCT03777319

  Collaborator, Phase 1, Terminated, 2 people, 17 Dec 2018

• NCT00790582

  Collaborator, Phase 2, Completed, 109 people, 13 Nov 2008

• NCT00484510

  Collaborator, Phase 2/3, Completed, 110 people, 11 Jun 2007

• NCT00005674

  Collaborator, Phase 2, Completed, 29 May 2000

• Abigail Mackey

  MDA Request for Applications, Regenerating healthy human skeletal muscle at single nucleus resolution, 1486091, 2026–2027, 1 Jan 2026

• Copenhagen University Hospital, Denmark

  MDA Request for Applications, Regenerating healthy human skeletal muscle at single nucleus resolution, 1486091, 2026–2027, 1 Jan 2026

• Bispebjerg Hospital

  MDA Request for Applications, Regenerating healthy human skeletal muscle at single nucleus resolution, 1486091, US$200k, 2026–2027, Lead, 1 Jan 2026

• Addolorata Pisconti

  Skeletal Muscle Stem Cells and Regeneration, 957304, 2022, 1 Jun 2022

• Pontificia Universidad Catolica de Chile

  Skeletal Muscle Stem Cells and Regeneration, 957304, 2022, 1 Jun 2022

• Federation of American Societies for Experimental Biology

  Skeletal Muscle Stem Cells and Regeneration, 957304, 8k, 2022, Lead, 1 Jun 2022

Sources: openalex.org

• Excessive activation of the RAS/MAPK pathway triggers adult-onset motor axonal degeneration

  MDA 946876, 21 Sept 2026

Sources: api.crossref.org